Immunovant Inc

-0.48 (-8.54%)
Earnings Announcements

Immunovant Reports Financial Results For The Quarter Ended June 30, 2022

Published: 08/05/2022 12:07 GMT
Immunovant Inc (IMVT) - Immunovant Reports Financial Results and Recent Business Updates for the Quarter Ended June 30, 2022.
Quarterly Loss per Share $0.35.
Expects to Continue to Incur Fluctuating Quarterly Operating Cash Flows in Future.
Cash Balance of $427 Million As of June 30, 2022 is Expected to Provide Cash Runway Into Calendar Year 2025.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.37

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.39

More details on our Analysts Page.